A phase II study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with pemetrexed in elderly patients with advanced epidermal growth factor receptor non-squamous non-small-cell lung cancer (LCEN1301)
Phase 2
Suspended
- Conditions
- Elderly patients with advanced non-squamous non-small-cell lung cance
- Registration Number
- JPRN-UMIN000013387
- Lead Sponsor
- ung Cancer Experts Network (LCEN)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pulmonary fibrosis and interstitial pneumonia on chest X-ray or symptomatic pulmonary fibrosis and interstitial pneumonia 2) SVC synd 3) Uncontrolled diabetes, myocardial infarction or cerebral infarction within the past 3 months 4) Infectious disease requiring systemic treatment 5) Psychotic disorder 6) Synchronous or metachronous active double malignancies 7) History of allergic reaction for agents of present treatment 8) Severe heart disease 9) Patients with immunotherapy or vaccine therapy 10) Other ineligible status judged by medical oncologist
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method